A chapter in the development on Alzheimer's disease research - A case study of public policies on the development & funding of research program

被引:0
|
作者
Khachaturian, Zaven S. [1 ]
机构
[1] Radebaugh & Associates Inc, Potomac, MD 20584 USA
关键词
D O I
10.1007/978-3-540-37652-1_6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although Alzheimer's disease, as a clinical-neuropathologic entity, was described one hundred years ago by Alois Alzheimer, the preponderance of knowledge on the disease was accumulated since the 1970s. The dramatic research advances during the last three decades propelled the disease from near obscurity to the forefront of modern biomedical science. The remarkable transformation of this field of study is reflected by the exponential increase in the numbers investigators, publications and funded projects. The current preeminence of dementia research is largely due to the increasing numbers and quality of significant breakthroughs in understanding the molecular neurobiology of the disease. Multiple promising leads now have created an atmosphere of optimism about the prospects of discovering effective interventions to delay the progression of the disease. Some of the key factors that influenced the pace of progress and helped to change the 'status' of dementia research were: a) increases in research funding, b) recruitment of new scientific talent; convergence of know-how and technologies, c) several crucial discoveries in molecular neurobiology and d) National Institute on Aging (NIA) initiatives to promote interdisciplinary research programs by creating nationwide network of collaborating investigators and the establishment research infrastructure/resource. This is an account how the evolution of Alzheimer research occurred; a story about critical findings, people and public policies that influenced the amazing progress in understanding the underlying molecular mechanisms of the disease and setting the stage for the discovery of a cure.
引用
收藏
页码:63 / 86
页数:24
相关论文
共 50 条
  • [21] NIA funding for Alzheimer's research
    Barr, Robin A.
    LANCET NEUROLOGY, 2011, 10 (08): : 683 - 683
  • [22] Determining quantitative targets for public funding of tuberculosis research and development
    Walwyn, David R.
    HEALTH RESEARCH POLICY AND SYSTEMS, 2013, 11
  • [23] Determining quantitative targets for public funding of tuberculosis research and development
    David R Walwyn
    Health Research Policy and Systems, 11
  • [24] The impact of public funding for research and development on business performance in Mexico
    Reyes, Delia Margarita Vergara
    Guerrero, Alex J.
    Diaz, Guillermo Arenas
    Heijs, Joost
    CEPAL REVIEW, 2024, (142): : 161 - 179
  • [25] Research on the Value Orientation of China's Public Policies in the Development of Cultural Industry
    Ji Jing-jing
    Li Xing-min
    PROCEEDINGS OF 2013 INTERNATIONAL CONFERENCE ON PUBLIC ADMINISTRATION (9TH), VOL II, 2013, : 88 - 93
  • [26] Government funding of research and development
    Grant, J
    Lewison, G
    SCIENCE, 1997, 278 (5339) : 878 - 879
  • [28] Government research and development funding
    Slavkin, HC
    ASAIO JOURNAL, 1997, 43 (06) : 880 - 881
  • [29] GOVERNMENT FUNDING OF RESEARCH AND DEVELOPMENT
    不详
    ENDEAVOUR, 1983, 7 (04) : 161 - 161
  • [30] Alzheimer's disease biomarker development: a call to funding bodies
    Frisoni, Giovanni B.
    Jack, Clifford R., Jr.
    Winblad, Bengt
    NEUROBIOLOGY OF AGING, 2017, 52 : 117 - 118